Publications by authors named "Cansu Atmaca Mutlu"

Claim this Profile
U
Use of gemtuzumab ozogamicin in relapsed refractory acute myeloid leukemia: Multi-center real life data from Turkey.
Ayşe Hilal Eroğlu Küçükdiler, İrfan Yavaşoğlu, Cem Selim, Cansu Atmaca Mutlu, Abdullah Karakuş

Leuk Res Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis